hydralazine has been researched along with resveratrol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, HD; Behbahani, J; Fandrich, R; Kardami, E; Louis, XL; Movahed, A; Netticadan, T; Thandapilly, SJ; Yu, L; Zhang, S | 1 |
Fukuda, K; Ishii, I; Ito, K; Katsumata, Y; Matsuhashi, T; Sano, M; Shinmura, K; Suematsu, M; Tamaki, K; Yamamoto, T; Yan, X | 1 |
2 other study(ies) available for hydralazine and resveratrol
Article | Year |
---|---|
Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Cardiovascular System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemodynamics; Hydralazine; Hypertension; Male; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Resveratrol; Stilbenes | 2013 |
Indispensable role of endothelial nitric oxide synthase in caloric restriction-induced cardioprotection against ischemia-reperfusion injury.
Topics: Animals; Caloric Restriction; Hydralazine; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type III; Resveratrol; Sirtuin 1; Stilbenes; Vasodilator Agents | 2015 |